Medicure (MCUJF) Current Deferred Revenue (2016 - 2022)

Medicure's Current Deferred Revenue history runs 7 years deep, the most recent figure standing at $131869.8 for Q4 2022.

• On a quarterly basis, Current Deferred Revenue fell 60.7% year-over-year to $131869.8 in Q4 2022; TTM through Dec 2022 was $131869.8, a 60.7% decrease from a year earlier, with the FY2022 full-year figure at $137680.7, down 59.21% from the prior year.
• Current Deferred Revenue declined to $131869.8 in Q4 2022 per MCUJF's latest filing, from $335581.2 in the prior quarter.
• Across five years, Current Deferred Revenue topped out at $1.1 million in Q4 2018 and bottomed at $131869.8 in Q4 2022.
• The 5-year median for Current Deferred Revenue is $371826.3 (2021), against an average of $491189.0.
• Across the five-year window, Current Deferred Revenue soared 186.95% in 2018 and slumped 60.7% in 2022, its largest moves.
• Year by year, Current Deferred Revenue stood at $1.1 million in 2018, then tumbled by 41.72% to $660538.6 in 2019, then slumped by 57.96% to $277673.8 in 2020, then rose by 20.85% to $335581.2 in 2021, then slumped by 60.7% to $131869.8 in 2022.
• Per Business Quant, the three latest MCUJF Current Deferred Revenue figures stand at $131869.8 (Q4 2022), $335581.2 (Q4 2021), and $277673.8 (Q4 2020).